This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Sator Therapeutics, Other. Active years: 2022-2026.
Company Filing History:
3 out of 3 
1 out of 834,307 Years Active: 2022-2026
Title: The Innovative Contributions of Peter M Chumakov
Introduction
Peter M Chumakov is a notable inventor based in Solon, OH (US). He has made significant contributions to the field of oncology through his innovative research and development of oncolytic viruses. With a total of 4 patents, his work focuses on methods to combat cancer effectively.
Latest Patents
One of his latest patents is titled "Optimized Oncolytic Viruses and Uses Thereof." This patent discloses methods for inhibiting or reducing tumor growth by administering a composition containing at least one selected oncolytic virus directly within a tumor of a patient. The virus is designed to kill cancerous cells while inducing a systemic and lasting anti-tumor immunity that is compatible with other cancer treatments. Additionally, the patent outlines methods for creating synthetic viruses specifically targeting cancerous tumors.
Career Highlights
Throughout his career, Peter has worked with various organizations, including Sator Therapeutics. His innovative approaches have positioned him as a key figure in the development of cancer therapies.
Collaborations
Peter has collaborated with notable professionals in his field, including Stephen A Charles and Natalia D Tararova. Their combined expertise has contributed to advancing research in oncolytic virus therapies.
Conclusion
Peter M Chumakov's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patents and collaborations highlight his commitment to developing effective cancer treatments.